Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation.

Henry G BoneM A WalterM E HurleyS Epstein

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2017)

There was no clinically important pharmacokinetic interference between the Aln-NEF formulation and LT4. Aln-NEF does not materially affect LT4 absorption.

Keyphrases

drug delivery